We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Multi-Center Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Moderate-to-Severe Crohn's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01155362
Recruitment Status : Completed
First Posted : July 1, 2010
Last Update Posted : July 16, 2014
Sponsor:
Information provided by (Responsible Party):
Celgene ( Celgene Corporation )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2012
  Study Completion Date : April 2014
  Certification or Request for Extension to Delay Results Submission: August 7, 2013